From: Mortality of lymphoma and myeloma in China, 2004–2017: an observational study
Subtype | ICD-10 |
---|---|
Hodgkin lymphoma | C81 |
Nodular lymphocyte predominant Hodgkin lymphoma | C81.0 |
Nodular sclerosis (classical) Hodgkin lymphoma | C81.1 |
Mixed cellularity (classical) Hodgkin lymphoma | C81.2 |
Lymphocyte-depleted (classical) Hodgkin lymphoma | C81.3 |
Lymphocyte-rich (classical) Hodgkin lymphoma | C81.4 |
Other (classical) Hodgkin lymphoma | C81.7 |
Hodgkin lymphoma, unspecified | C81.9 |
Follicular lymphoma | C82 |
Follicular lymphoma grade I | C82.0 |
Follicular lymphoma grade II | C82.1 |
Follicular lymphoma grade III, unspecified | C82.2 |
Follicular lymphoma grade IIIa | C82.3 |
Follicular lymphoma grade IIIb | C82.4 |
Diffuse follicle center lymphoma | C82.5 |
Cutaneous follicle center lymphoma | C82.6 |
Other types of follicular lymphoma | C82.7 |
Follicular lymphoma, unspecified | C82.9 |
Non-follicular lymphoma | C83 |
Small cell B cell lymphoma | C83.0 |
Mantle cell lymphoma | C83.1 |
Diffuse large B cell lymphoma | C83.3 |
Lymphoblastic (diffuse) lymphoma | C83.5 |
Burkitt lymphoma | C83.7 |
Other non-follicular lymphoma | C83.8 |
Non-follicular (diffuse) lymphoma, unspecified | C83.9 |
Mature T/NK cell lymphomas | C84 |
Mycosis fungoides | C84.0 |
Sézary disease | C84.1 |
Peripheral T cell lymphoma, not elsewhere classified | C84.4 |
Other mature T/NK cell lymphomas | C84.5 |
Anaplastic large cell lymphoma, ALK-positive | C84.6 |
Anaplastic large cell lymphoma, ALK-negative | C84.7 |
Cutaneous T cell lymphoma, unspecified | C84.8 |
Mature T/NK cell lymphoma, unspecified | C84.9 |
Other and unspecified types of non-Hodgkin lymphoma | C85 |
B cell lymphoma, unspecified | C85.1 |
Mediastinal (thymic) large B cell lymphoma | C85.2 |
Other specified types of non-Hodgkin lymphoma | C85.7 |
Non-Hodgkin lymphoma, unspecified | C85.9 |
Other specified types of T/NK cell lymphoma | C86 |
Extranodal NK/T cell lymphoma, nasal type | C86.0 |
Hepatosplenic T cell lymphoma | C86.1 |
Enteropathy-type (intestinal) T cell lymphoma | C86.2 |
Subcutaneous panniculitis-like T cell lymphoma | C86.3 |
Blastic NK cell lymphoma | C86.4 |
Angioimmunoblastic T cell lymphoma | C86.5 |
Primary cutaneous CD30-positive T cell proliferations | C86.6 |
Malignant immunoproliferative diseases | C88 |
Waldenström macroglobulinemia | C88.0 |
Other heavy chain diseases | C88.2 |
Immunoproliferative small intestinal disease | C88.3 |
Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue [MALT lymphoma] | C88.4 |
Other malignant immunoproliferative diseases | C88.7 |
Malignant immunoproliferative disease, unspecified | C88.9 |
Multiple myeloma and malignant plasma cell neoplasms | C90 |
Multiple myeloma | C90.0 |
Plasma cell leukemia | C90.1 |
Extramedullary plasmacytoma | C90.2 |
Solitary plasmacytoma | C90.3 |
Other and unspecified malignant neoplasms of lymphoid, hematopoietic, and related tissue | C96 |
Multifocal and multisystemic (disseminated) Langerhans cell histiocytosis [Letterer-Siwe disease] | C96.0 |
Malignant mast cell tumor | C96.2 |
Sarcoma of dendritic cells (accessory cells) | C96.4 |
Multifocal and unisystemic Langerhans cell histiocytosis | C96.5 |
Unifocal Langerhans cell histiocytosis | C96.6 |
Other specified malignant neoplasms of lymphoid, hematopoietic, and related tissue | C96.7 |
Histiocytic sarcoma | C96.8 |
Malignant neoplasm of lymphoid, hematopoietic, and related tissue, unspecified | C96.9 |